THE ARIZONA PARTNERSHIP FOR IMMUNIZATION NPI 1942532189

NPI Details

THE ARIZONA PARTNERSHIP FOR IMMUNIZATION is a public health or welfare in Phoenix, AZ. THE ARIZONA PARTNERSHIP FOR IMMUNIZATION NPI is 1942532189. The provider is registered as an organization entity type.
The provider .

The provider's business location address is:

3838 N CENTRAL AVE STE 1650
PHOENIX, AZ
ZIP 85012-906
Phone: (602) 288-7572
Fax: (602) 218-3906

The provider's authorized official is James Washington .
The authorized official title is Ceo and has the following contact phone number (602) 288-7566.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Coronavirus vaccine 14 (HCPCS:91313)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Coronavirus vaccine 13 (HCPCS:91312)
• Sarscov2 vac 30 mcg trs-sucr (HCPCS:91305)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Smallpox&monkeypox vac 0.5ml (HCPCS:90611)
• Administration of vaccine (HCPCS:90471)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home (HCPCS:M0201)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage, for intramuscular use (HCPCS:91303)
• Adm sarscov2 vac ad26 .5ml b (HCPCS:0034A)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose (HCPCS:0012A)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Adm sarscv2 30mcg trs-sucr 1 (HCPCS:0051A)

The enumeration date for this NPI number is 2/12/2010 and was last updated on 2/4/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: